Incorporating Structured and Unstructured Data Sources to Identify and Characterize Hereditary Cancer Testing Among Veterans With Metastatic Castration-Resistant Prostate Cancer
Although testing rates are still suboptimal, they have increased steadily since 2016. Educating Veterans about the benefits of genetic testing may further improve testing rates.
Authors
- Yu-Ning Wong
- Nai-Chung Chang (ORCID: https://orcid.org/0000-0002-4541-8967)
- Scott L. DuVall (ORCID: https://orcid.org/0000-0002-4898-3865)
- Kathryn M. Pridgen
- Mengke Hu (ORCID: https://orcid.org/0000-0001-9421-6432)
- Fatai Y. Agiri (ORCID: https://orcid.org/0009-0004-6701-3559)
- Danielle Candelieri-Surette (ORCID: https://orcid.org/0009-0008-8750-6720)
- Julie Ann Lynch (ORCID: https://orcid.org/0000-0003-0108-2127)
- Martin William Schoen (ORCID: https://orcid.org/0000-0001-6388-5553)
- Anna Hung (ORCID: https://orcid.org/0000-0002-0730-431X)
- Jeffrey Shevach (ORCID: https://orcid.org/0000-0002-3982-781X)
- Ming Yin (ORCID: https://orcid.org/0000-0001-5743-4369)
- Elizabeth E Hanchrow
- Patrick R. Alba (ORCID: https://orcid.org/0000-0002-5176-5447)
- Weiyan Li (ORCID: https://orcid.org/0000-0002-1803-8088)
- Tyler J. Nelson (ORCID: https://orcid.org/0000-0001-5216-7337)
- Kyung Min Lee (ORCID: https://orcid.org/0000-0001-8995-0448)
- Anthony Gao (ORCID: https://orcid.org/0000-0001-6781-7873)
Institutions
- Duke University (US)
- University of Utah (US)
- Clinical Research Institute (US)
- VA Salt Lake City Healthcare System (US)
- Duke Medical Center (US)
- Philadelphia VA Medical Center (US)
- Durham VA Medical Center (US)
- AstraZeneca (United States) (US)
- VA St. Louis Health Care System (US)
- Saint Louis University (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- JCO Clinical Cancer Informatics
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1200/cci-24-00189
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Veterans Affairs
- Abbott Laboratories
- LUNGevity Foundation
- AstraZeneca
- GlaxoSmithKline
- Alnylam Pharmaceuticals
- Celgene
- Parexel
- Moderna
- Astellas Pharma
- Genentech